CytRx announced this week that it has appointed Gregory Liberman as the company’s general counsel and corporate secretary.
In these roles, CytRx said that Liberman is responsible for managing the company’s worldwide legal affairs, policy, and strategy. He will report to CytRx CEO Steven Kriegsman and will serve as secretary to the company’s board of directors.
Liberman has previously worked as a strategic consultant to both private and public companies, said CytRx. He has also served as vice president of legal and corporate affairs, as well as associate general counsel, at Exodus Communications. Prior to this, he was vice president of corporate development and associate general counsel at GlobalCenter.
Lieberman holds a JD from the University of Chicago Law School.
CytRx also announced this week that Robert Brown, founder and director of the Cecil B. Day Laboratory of Neuromuscular Research at Massachusetts General Hospital, has joined the company’s scientific advisory board.
Brown is a professor of neurology at Harvard Medical School and is a recognized expert in the field of neuromuscular diseases such as amyotrophic lateral sclerosis, said CytRx.
Brown is also a member of the Institute of Medicine, the Academy of Neurology, and the American Neurological Association, said the company. He graduated from Harvard Medical School and completed his doctoral training at Oxford University.